Mana Capital Acquisition

MAAQ

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization15.8M

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

What share of all stock conversation is about MAAQ?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Mana Capital Acquisition Corp. ($MAAQ) has completed its merger with Cardio Diagnostics ($CDIO) and is trading at $8.88, up 13.8% from $7.80.
The deal includes rights for shareholders, but no information is available on potential redemptions.
$MAAQ is experiencing selling pressure ahead of the merger, despite its recent price increase.

Generated by AI

Of the messages about MAAQ that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	—
Bearish	—	—	—	—

Of the messages about MAAQ that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Mana Capital Acquisition Corp. ($MAAQ) has entered into a definitive business combination agreement with Cardio Diagnostics, Inc. to create a publicly listed company.
The combined company will be renamed Cardio Diagnostics and is expected to remain listed on the Nasdaq Global Market under a new ticker symbol $CDIO.
The deal is aimed at transforming cardiovascular disease through epigenetics using Cardio Diagnostics' proprietary artificial intelligence-driven Integrated Genetic-Epigenetic Engine.

Generated by AI

Of the messages about MAAQ, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	—
Newcomers	—	—	—	—

Mana Capital Acquisition Corp.

United States